Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Antibiotics for bacterial pneumonia in children

세균성 폐렴과 항생제 선택

  • Yum, Hye-yung (Department of Pediatrics, Atopy Clinic, Seoul Medical Center)
  • 염혜영 (서울의료원 아토피클리닉 소아청소년과)
  • Received : 2009.02.02
  • Accepted : 2009.02.13
  • Published : 2009.03.15
Download PDF
⟨ Previous Next ⟩

Abstract

Pneumonia remains the leading cause of mortality in children. Diagnosis depends on a combination of factors, including clinical assessment, radiological and laboratory findings. Although Streptococcus pneumoniae remains the most important cause of childhood bacterial pneumonia, the great majority of cases of community-acquired pneumonia (CAP) are of viral etiology. A new, rapid, and inexpensive test that differentiates viral from bacterial pneumonia is needed to decide empiric antibiotic treatment. Antibiotics effective against the expected bacterial pathogens should be instituted where necessary. The role of emerging pathogens and the effect of pneumococcal resistance and heptavalent conjugate pneumococcal vaccines are to be considered in practice. There are reports supporting the valid and highly efficacious use of penicillin as a first-line drug for treating CAP. This review raises the issue of the overuse of unnecessary antibiotics in viral CAPs and the use of second or third-line antibiotics for non-complicated pneumonias in most clinical settings.

Keywords

References

  1. Nascimento-Carvalho CMC. Etiology of childhood community-acquired pneumonia and its implication for vaccination. Braz J Infect Dis 2001;5:87-97
  2. Williams BG, Gouws E, Boshi-Pinto C, Bryce J. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis 2002;25-32 https://doi.org/10.1016/S1473-3099(01)00170-0
  3. Bryce J, Boschi-Pinto C, Shibuya K, Black RE. WHO estimates of the causes of death in children. Lancet 2005;365: 1147-52 https://doi.org/10.1016/S0140-6736(05)71877-8
  4. Mullholland K. Magnitude of the problem of childhood pneumonia. Lancet 1999;354:590-2 https://doi.org/10.1016/S0140-6736(98)10238-6
  5. McIntosh K. Community-acquired pneumonia in children. N Eng J Med 2002;346:429-37 https://doi.org/10.1056/NEJMra011994
  6. World Health Organization. The management of acute respiratory infections in children. Practical guidelines for outpatient care. Geneva: WHO, 1995
  7. Mahabee-Gitten EM, Grupp-Phelan J, Brody AS, Donnelly LF, Bracey SE, Duma EM, et al. Identifying children with pneumonia in the emergency department. Clin Pediatr 2005; 427-35 https://doi.org/10.1177/000992280504400508
  8. Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, et al. Epidemiology and cllinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004;113:701-7 https://doi.org/10.1542/peds.113.4.701
  9. British Thoracic Society. British Thoracic Society guidelines for the management of community acquired pneumonia in childhood. Thorax 2002;57 Suppl 1:i1-24
  10. Jadavji T, Law B, Lebel MH, Kennedy WA, Gold R, Wang EEL. A practical guide for the diagnosis and treatment of pediatric pneumonia. Can Med Assoc J 1997;156:703S-11S
  11. Cherian T, Mulholland EK, Carlin JB, Ostensen H, Amin R, de Campo M, et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ 2005;83:353-9
  12. Virkki R, Juven T, Rikalainen H, Svedstrom E, Mertosola J, Ruuskanen O. Differentiation of bacterial and viral pneumonia in children. Thorax 2002;57:438-41 https://doi.org/10.1136/thorax.57.5.438
  13. Heiskanen-Kosm T, Korppi M, Jokinene C. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J 1998;17:986-91 https://doi.org/10.1097/00006454-199811000-00004
  14. Michelow IC, Olsen K, Lozano J. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004;701-7
  15. Yum HY, Kim WK, Kim JT, Rha YH, Park YM, Sohn MH, et al. The causative organisms of pediatric empyema in Korea. Korean J Pediatr 2007;50:33-9 https://doi.org/10.3345/kjp.2007.50.1.33
  16. Khanna M, Fan J, Pehler-Harrington K. The pneumoplex assays, a multiplex PCR-enzyme hybridizaion assay thet allow simultaneous detection of five organisms, M pneumoniae, C. pneumoniae, L. pneumophilia, L. micdadei, B. pertussis, and its real-time counterpart. J Clin Microbiol 2005; 565-71
  17. Gutierrez F, Masia M, Rodriguez JC. Evaluation of the immunochromatographic Binax NOW assay for detection of S. pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. Clin Infect Dis 2003;36:286-92 https://doi.org/10.1086/345852
  18. Friis B, Andersen P, Brenoe E, Hornsleth A, Jensen A, Knudsen FU, et al. Antibiotic treatment of pneumonia and bronchiolitis. Arch Dis Child 1984;59:108-45
  19. Nelson JD. Community-acquired pneumonia in children: Guidelines for treatment . Pediatr Infect Dis J 2000;19:251-3 https://doi.org/10.1097/00006454-200003000-00016
  20. Addo-Yobo E, Chisaka N, Hassan M, Hibberd P, Lozano JM, Jeen P, et al. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomized multicentre equivalency study. Lancet 2004;364:1141-8 https://doi.org/10.1016/S0140-6736(04)17100-6
  21. Vuori-Holopainen E, Pltola H, Kallio MJ. Narrow- versus broad-spectrum parenteral antimicrobials against common infections of childhood: prospective and randomized comparison between penicillin and cefuroxime. Eur J Pediatr 2000;159:878-84 https://doi.org/10.1007/PL00008360
  22. Romano A, Gueant-Rodriguez RM, Viola M, Pettinato R, Gueant JL. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med 2004;141:16-22
  23. Hale KA, Isaacs D. Antibiotics in childhood pneumonia. Pediatr Res Rev 2006;7:145-51 https://doi.org/10.1016/j.prrv.2006.03.011
  24. Zar HJ, Cotton MF. Nosocomial pneumonia in pediatric patients: practical problems and rational solutions. Pediatr Drugs 2002;4:73-83
  25. Richards MJ, Edwards JR, Culver DH, Gaynes RP, the National Nosocomial Infections Surveillance System. Nosocomial infections in pediatric intensive care units in the United States. Pediatrics 1999;103:4:e39 https://doi.org/10.1542/peds.103.4.e39
  26. Low D. Pichichero ME, Schaad UB. Optimizing antibacterial therapy for community-acquired respiratory tract infection in children in the era of bacterial resistance. Clin Pediatr 2004;43:135-51 https://doi.org/10.1177/000992280404300203
  27. Song JH, Oh WS, Kang CI, Chung DR, Peck KR, Ko KS, et al. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. Int J Antimicrob Agents 2008;31:107-14 https://doi.org/10.1016/j.ijantimicag.2007.09.014
  28. Hefelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Marby LR, Musher DM, et al. Management of community- acquired pneumonia in the era of pneumococcal resistance. Arch Intern Med 2000;160:1399-408 https://doi.org/10.1001/archinte.160.10.1399
  29. Haddy RI, Perry K, Chacko CE, Helton WB, Bowling MG, Looney SW et al. Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated Pneumococcal Vaccine. Pediatr Infect Dis J 2005;113:1735-40
  30. Choi KM, Yeon SI, Shin JS, Yong DE, Lee KW, Kim DS. Serotype and antimicrobial susceptibility of Streptococcus pneumoniae. Infect Chemother 2006;38:179-85
  31. Black SB, Shinefield HR, Ling S, Hansen J, Fireman B, Spring D, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 2002; 21:810-5 https://doi.org/10.1097/00006454-200209000-00005
  32. Choi EH, Kim SH, Eun BW, Kim SJ, Kim NH, Lee J, et al. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis 2008;14:275-81 https://doi.org/10.3201/eid1402.070807

Cited by

  1. Impact of Revised Penicillin Breakpoints forStreptococcus pneumoniae(CLSI M100-S18) on the Penicillin Susceptibility Rate vol.13, pp.2, 2009, https://doi.org/10.5145/kjcm.2010.13.2.68
  2. 최근 4년간 국내 단일 의료기관을 내원한 소아청소년에서 분리된 폐구균의 항생제 감수성 양상 분석 vol.26, pp.1, 2009, https://doi.org/10.14776/piv.2019.26.e1